KNect365_CMC retweeted
Your smartphone can now tell you if you have a heart condition engt.co/1qt6Jwn
KNect365_CMC retweeted
Novel Treatment Destroys Brain Cancer Cells from the Inside emdt.co.uk/daily-buzz/novel-…
KNect365_CMC retweeted
Don’t miss your chance to hear exclusive information on the finalisation of ICH M7 #GTI2014 : informa-ls.com/CQ5231PMPST1
KNect365_CMC retweeted
Europe & America’s only event solely focused on Genotoxic impurity assessment and evaluation. Check out #GTI2014 http://t.co/a3cDdLgkE1
KNect365_CMC retweeted
New Target for Alzheimers Drug Development, University of Minnesota Study biospace.com/News/new-target… #socpharm #biotech
KNect365_CMC retweeted
We've updated our guideline for companies on how to study drug #interactions. Effective from 1 January 2013: http://t.co/vsCCTqKs
KNect365_CMC retweeted
Are manufacturers correctly assessing the costs of "low cost" countries? http://t.co/g3N8N4ZG
KNect365_CMC retweeted
Pharma News: Opko Health to purchase shares in Israeli hepatitis B vaccine manufacturer ow.ly/1kk1xr
KNect365_CMC retweeted
Informa's Analytical Method Development conference has now launched! Visit website & take a look at the brochure: informaglobalevents.com/CQ51…
KNect365_CMC retweeted
New Feature on analytical methods for characterizing Gd(III) MRI probes http://t.co/n18JcWMu
KNect365_CMC retweeted
sciencealerts.com Validation of micro-CT against the section method regarding the assessment of marginal leakage... dlvr.it/1cwDZ5
KNect365_CMC retweeted
Analytical Method Development Validation and Transfer 2012 in September Berlin http www clocate com 30493 clocate.com/30493
KNect365_CMC retweeted
Analytical Method Development Validation and Transfer 2012 in September Berlin clocate.com/30493
KNect365_CMC retweeted
Sneak previews of presentations at Outsourcing Manufacturing and Analytics available to download from ow.ly/awRJo #Outsource2012
KNect365_CMC retweeted
Speaker views on biggest challenges when working with CMO and #CROs to be made available from ow.ly/awR3C #Outsourcing2012
KNect365_CMC retweeted
Replying to @SigmaAldrich
@SigmaAldrich discuss targeted #genome editing with #zincfingernucleases (#ZFN) to create powerful new #cellular models ow.ly/asvwD
KNect365_CMC retweeted
Boehringer blood thinner #Pradaxa hits blockbuster mark over the 12 mos. ended in Feb. $828mn for 2011—WSJ on.wsj.com/I2AiPR #pharma
KNect365_CMC retweeted
Government to speed up access to new cancer drugs - ow.ly/atAct


















